Cataract Refractive Suite Study

Stopped early · Not applicable

Conditions studied: Cataracts

In brief

The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative

Key facts

Study ID

NCT02974140

Run by

Alcon, a Novartis Company

People needed

39

Starts

2017-03-02

Expected to finish

2017-07-25

Last updated by the study team

2018-09-14

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with bilateral cataracts;
• Planned cataract surgery and implantation of ReSTOR +2.5 D multifocal intraocular lens (IOL) in both eyes;
• Clear intraocular media, other than cataract, in study eye(s);
• Willing and able to complete all required postoperative visits;
• Able to comprehend and sign a statement of informed consent;
• Other protocol-specified inclusion criteria may apply.

You may not qualify if…

• Significant irregular corneal astigmatism;
• History of or current severe dry eyes, retinal/uveal pathology or concurrent ocular disease;
• Previous intraocular or corneal refractive surgery, corneal transplant, or retinal detachment;
• Any inflammation or edema (swelling) of the cornea;
• Pregnant;
• Other protocol-specified exclusion criteria may apply.

Where it is running

• Alcon Investigative Site — Panama City, Florida, United States
• Alcon Investigative Site — Stillwater, Minnesota, United States
• Alcon Investigative Site — Hurst, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.